Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer.

Cancers (Basel) · 2023 · PMC9856297 · PMID 36672492

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

The effectiveness of this combination was established in both PD-L1 positive as well as negative NSCLC patients; 23% of ORR was achieved on administering the combination, which is quite significant, as it was observed regardless of the PD-L1 status.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.